Company Profile
AimsBio is a diversified privately-owned biotechnology company that researches and develops novel pharmaceuticals, diagnostic kits, and analytical services. The company is currently operating in three divisions: AimsBio-Pharma, AimsBio-Health, and AimsBio-Analytics. From these divisions, three core technologies exist. First, the company is researching novel natural product antibiotics for the treatment of serious infections in the pharmaceutical market. Secondly, the company is commercializing novel technologies in the rapid and low cost diagnostics of amino acids in blood serum and urine for the health care market. Thirdly, the company offers high-throughput low cost analytical services to the health care, diagnostic, and agricultural markets.
| Pharmaceuticals |
 |
Human Diagnostics |
 |
| Med or Lab Devices |
|
Lab Reagents or Services |
|
| Drug Manufacturing |
|
Food & Agribusiness |
 |
| CRO |
|
Bioinformatics or Software |
|
| |
|
Other |
|
|